HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats.

Abstract
Phosphodiesterase inhibitors have been reported to be beneficial in cognitive and motor disorders. In the present study, we have investigated the effects of RO 20-1724 (PDE4 inhibitor) and sildenafil (PDE5 inhibitor) in 3-nitropropionic acid (3-NP) induced experimental Huntington's disease in rats. 3-Nitropropionic acid was administered for 14 days (10 mg/kg i.p.) 1h following 3-NP administration, the rats were treated with either vehicle, RO 20-1724 (0.25 and 0.5 mg/kg i.p.) or sildenafil (2 and 4 mg/kg i.p.) for 14 days. Cognitive functions were assessed by using Morris water maze whereas, motor functions were assessed by spontaneous locomotor activity, limb withdrawal and suspended wire test at different time points. Biochemically, markers of oxidative stress and cell damage, such as reduced glutathione, malondialdehyde, nitrite and lactate dehydrogenase levels were assessed terminally in the brain homogenate. Chronic administration of 3-NP produced significant decrease in body weight, showed marked abnormalities in cognitive and motor functions. Further, significant oxidative-nitrosative stress and cell damage was also observed. Chronic administration of RO 20-1724 and sildenafil in 3-NP treated rats significantly and dose dependently attenuated 3-NP induced behavioral and biochemical abnormalities in rats. Both these drugs were equally effective in attenuating 3-NP induced neurotoxicity. These results suggesting that the inhibition of PDE4 and PDE5 would be therapeutic in neurodegenerative disorders associated with cognitive and motor dysfunction.
AuthorsTarun Thakur, Sorabh Sharma, Kushal Kumar, Rahul Deshmukh, Pyare Lal Sharma
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 714 Issue 1-3 Pg. 515-21 (Aug 15 2013) ISSN: 1879-0712 [Electronic] Netherlands
PMID23831390 (Publication Type: Journal Article)
Copyright© 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Neuroprotective Agents
  • Nitro Compounds
  • Phosphodiesterase 4 Inhibitors
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Propionates
  • Purines
  • Sulfones
  • 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
  • Malondialdehyde
  • Sildenafil Citrate
  • L-Lactate Dehydrogenase
  • Succinate Dehydrogenase
  • Glutathione
  • 3-nitropropionic acid
Topics
  • 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (pharmacology)
  • Animals
  • Behavior, Animal (drug effects)
  • Body Weight (drug effects)
  • Brain (drug effects, enzymology, metabolism)
  • Glutathione (metabolism)
  • L-Lactate Dehydrogenase (metabolism)
  • Malondialdehyde (metabolism)
  • Maze Learning (drug effects, physiology)
  • Memory (drug effects)
  • Neuroprotective Agents (pharmacology)
  • Nitro Compounds (toxicity)
  • Phosphodiesterase 4 Inhibitors (pharmacology)
  • Phosphodiesterase 5 Inhibitors (pharmacology)
  • Piperazines (pharmacology)
  • Propionates (toxicity)
  • Purines (pharmacology)
  • Rats
  • Rats, Wistar
  • Sildenafil Citrate
  • Succinate Dehydrogenase (metabolism)
  • Sulfones (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: